Views & Analysis - Pharmaphorum

Trending

Latest Views & analysis

in Views and analysis

How the EU’s GDPR will be a positive catalyst for change
June 14, 2018 Share
X
How the EU’s GDPR will be a positive catalyst for change
https://pharmaphorum.com/views-analysis-digital/gdpr/
in Views and analysis

The user experience in your clinical trials: it really matters
May 16, 2018 Share
X
The user experience in your clinical trials: it really matters
https://pharmaphorum.com/r-d/views-analysis-r-d/the-user-experience-in-your-clinical-trials-it-really-matters/

How Merck is stepping up for patients

How Merck is stepping up for patients

Patient centricity is a priority for Merck and its Executive Vice President and Head of EMEA Region, Chris Round, outlines what practical steps the company is taking to improve life for patients and carers.

X

How Merck is stepping up for patients

https://pharmaphorum.com/views-analysis-patients/how-merck-is-stepping-up-for-patients/

Can ‘design thinking’ revolutionise pharma’s culture?

Can ‘design thinking’ revolutionise pharma’s culture?

As part of pharmaphorum’s ‘eye-on-innovation’ series, Paul Tunnah speaks to UCB’s head of innovation, Gregory Miller, about how

X

Can ‘design thinking’ revolutionise pharma’s culture?

https://pharmaphorum.com/views-and-analysis/can-design-thinking-revolutionise-pharmas-culture/

Pharma must live and breathe patient centricity

Pharma must live and breathe patient centricity

Patient-centric programmes that ignore the ‘BREATHE’ principles will fail to hit the mark and leave patients behind, according

X

Pharma must live and breathe patient centricity

https://pharmaphorum.com/views-analysis-patients/pharma-must-live-and-breathe-patient-centricity/

More Views & Analysis

Resourcing HTA across Europe

Resourcing HTA across Europe

With the European Commission looking to formally strengthen health technology assessment (HTA) across Member States, Leela Barham attempts to

X

Resourcing HTA across Europe

https://pharmaphorum.com/views-analysis-market-access/resourcing-hta-across-europe/

Could digital technology revolutionise pharma in 2018?

Could digital technology revolutionise pharma in 2018?

This year’s eyeforpharma conference in Barcelona outlined how 2018 could be a turning point for the industry. As

X

Could digital technology revolutionise pharma in 2018?

https://pharmaphorum.com/views-and-analysis/digital-technology-revolutionise-pharma-2018/

Cementing the Value of Medical Affairs

Cementing the Value of Medical Affairs

A number of trends including tougher regulatory controls, increased transparency expectations, an increasingly vocal patient and greater requirements

X

Cementing the Value of Medical Affairs

https://pharmaphorum.com/views-analysis-sales-marketing/cementing-value-medical-affairs/

Five lessons for effective pharma market research

Five lessons for effective pharma market research

Market research can identify ways to lower costs and improve revenues, if it is approached methodically. Here are some tips for success.

X

Five lessons for effective pharma market research

https://pharmaphorum.com/views-and-analysis/five-lessons-effective-pharma-market-research/

Improving oncology KOL engagement

Improving oncology KOL engagement

Combining technology with human insights is a powerful tool in identifying and engaging effectively with oncology experts.

X

Improving oncology KOL engagement

https://pharmaphorum.com/views-analysis-sales-marketing/improving-oncology-kol-engagement/

Rethinking the communication of clinical trial results

Rethinking the communication of clinical trial results

If clinical trial results were more quickly and openly accessible, medical improvements would be implemented more swiftly too.

X

Rethinking the communication of clinical trial results

https://pharmaphorum.com/views-analysis-market-access/rethinking-communication-clinical-trial-results/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com